Evidence map›Paper›PMID 35034853›Full record

SynthesisGenetics in medicine : official journal of the American College of Medical Genetics2022

Identification of 4 novel human ocular coloboma genes ANK3, BMPR1B, PDGFRA, and CDH4 through evolutionary conserved vertebrate gene analysis.

Nicholas Owen, Maria Toms, Rodrigo M Young, Jonathan Eintracht, Hajrah Sarkar, Brian P Brooks, Mariya Moosajee, Genomics England Research Consortium

Open access · hybridAbstract readMeta-Analysis
In one paragraph

Synthesis in Genetics in medicine : official journal of the American College of Medical Genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Holoprosencephaly and cyclopia inAnimal cells and systems · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Nicholas OwenDevelopment, Ageing and Disease, UCL Institute of Ophthalmology, London, United Kingdom.
Maria TomsDevelopment, Ageing and Disease, UCL Institute of Ophthalmology, London, United Kingdom.
Rodrigo M YoungDevelopment, Ageing and Disease, UCL Institute of Ophthalmology, London, United Kingdom.
Jonathan EintrachtDevelopment, Ageing and Disease, UCL Institute of Ophthalmology, London, United Kingdom.
Hajrah SarkarDevelopment, Ageing and Disease, UCL Institute of Ophthalmology, London, United Kingdom.
Brian P BrooksOphthalmic Genetics and Visual Function Branch, National Eye Institute, National Institutes of Health, Bethesda, MD.
Mariya MoosajeeDevelopment, Ageing and Disease, UCL Institute of Ophthalmology, London, United Kingdom; Department of Genetics, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom; Department of Ophthalmology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom; Ocular Genomics and Therapeutics, The Francis Crick Institute, London, United Kingdom. Electronic address: m.moosajee@ucl.ac.uk.
Genomics England Research Consortium
University College London · GBNational Institutes of Health · USNational Eye Institute · USGenomics (United Kingdom) · GBMoorfields Eye Hospital · GB

Funding

The Genetics of Uveal ColobomaZIAEY000469 · NEI · NATIONAL EYE INSTITUTE · PI BROOKS, BRIAN · 2009 to 2025
$35.2M
Intramural NIH HHS ZIA EY000469Medical Research Council MC_EX_MR/M009203/1Medical Research Council MC_PC_14089Medical Research Council MR/M009203/1Wellcome TrustWellcome Trust 205174/Z/16/Z
6 · The paper itself

Abstract

purposeOcular coloboma arises from genetic or environmental perturbations that inhibit optic fissure (OF) fusion during early eye development. Despite high genetic heterogeneity, 70% to 85% of patients remain molecularly undiagnosed. In this study, we have identified new potential causative genes using cross-species comparative meta-analysis.

methodsEvolutionarily conserved differentially expressed genes were identified through in silico analysis, with in situ hybridization, gene knockdown, and rescue performed to confirm spatiotemporal gene expression and phenotype. Interrogation of the 100,000 Genomes Project for putative pathogenic variants was performed.

resultsNine conserved differentially expressed genes between zebrafish and mouse were identified. Expression of zebrafish ank3a, bmpr1ba/b, cdh4, and pdgfaa was localized to the OF, periocular mesenchyme cells, or ciliary marginal zone, regions traversed by the OF. Knockdown of ank3, bmpr1b, and pdgfaa revealed a coloboma and/or microphthalmia phenotype. Novel pathogenic variants in ANK3, BMPR1B, PDGFRA, and CDH4 were identified in 8 unrelated coloboma families. We showed BMPR1B rescued the knockdown phenotype but variant messenger RNAs failed, providing evidence of pathogenicity.

conclusionWe show the utility of cross-species meta-analysis to identify several novel coloboma disease-causing genes. There is a potential to increase the diagnostic yield for new and unsolved patients while adding to our understanding of the genetic basis of OF morphogenesis.

Indexed as

ColobomaMicrophthalmosAnimalsAnkyrinsBone Morphogenetic Protein Receptors, Type IGenetic TestingHumansMicePhenotypeZebrafishANK3 protein, humanAnkyrinsBMPR1B protein, humanBone Morphogenetic Protein Receptors, Type IColobomaCongenital eye defectsDisease geneticsGenomic sequencingMicrophthalmia

Identifiers

PMID35034853
PMCPMC11505079
OpenAlexW4205845813

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.